Corporate Governance

Corporate Governance Overview

The Board of Directors of Elicio Therapeutics Inc. (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Committee Composition

Audit
Compensation
Nominating and Corporate Governance Committee
Julian Adams, PhD
( Chair of the Board )
Member
Chair
Carol Ashe
Member
Chair
Member
Yekaterina Chudnovsky
Member
Allen Nissenson, MD
Member
Robert R. Ruffolo, Jr., PhD, FCPP
Member
Jay Venkatesean, MD, MBA
Karen J. Wilson
Chair
Member
Chair
Member

Board Diversity Matrix

The following Board Diversity Matrix presents our Board diversity statistics in accordance with Nasdaq Rule 5606, as self-disclosed by our directors. As we pursue future Board recruitment efforts, our Nominating and Corporate Governance Committee will continue to seek out candidates who can contribute to the diversity of views and perspectives of our Board.

As of September 12, 2023
Total Number of Directors 8  
  Female Male
Gender Identity:    
Directors 3 5
Demographic Background:    
South Asian 1
White 2 4
Did not Disclose Demographic Background 1

Investor Relations Contact

Heather DiVecchia
Elicio Therapeutics
Tel: (857) 209-0153
IR@elicio.com

Email Alerts Sign-Up